Fig. 1From: Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern IrelandKaplan-Meier curve for PFS for patients treated with combination doxorubicin and olaratumab (1) all patients (2) leiomyosarcoma (3) undifferentiated pleomorphic sarcoma (UPS) (4) liposarcomaBack to article page